Estimating the long-term costs of diabetic kidney disease: an economic approach

Mark Knezevic

Applied Economics Letters, 2009, vol. 16, issue 10, 1059-1064

Abstract: Healthcare spending in Australia has increased rapidly in recent decades, partly due to the prevalence of lifestyle related illness, as physical inactivity and ageing have become common. Diabetes is a chronic and costly illness resulting from poor lifestyle choice and ageing. In this study, we estimate the long-run cumulative costs of a complication of diabetes, diabetic kidney disease, using well-known techniques from health economics. We find that spending on treatment for diabetic kidney disease will amount to $9.2 billion over the next 30 years. Most of the cost from this complication comes from the clinical stage of diabetic kidney disease.

Date: 2009
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.informaworld.com/openurl?genre=article& ... 40C6AD35DC6213A474B5 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:taf:apeclt:v:16:y:2009:i:10:p:1059-1064

Ordering information: This journal article can be ordered from
http://www.tandfonline.com/pricing/journal/RAEL20

DOI: 10.1080/13504850701335301

Access Statistics for this article

Applied Economics Letters is currently edited by Anita Phillips

More articles in Applied Economics Letters from Taylor & Francis Journals
Bibliographic data for series maintained by Chris Longhurst ().